Skip to main content

Advertisement

Table 2 Rate of resistances to SXT, TE, CIP and G among ESBLs and Non ESBL

From: Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania

Isolates SXT (% R) TE (% R) CIP (% R) G (% R)
Acinetobacter spp (n = 39) 87.2 84.6 43.6 76.9
   Non ESBL (n = 32) 65.6 62.5 25 53
ESBL (n = 7) 100 100 43 100
Escherichia coli (n = 127) 65.4 59.1 33.1 29.1
   Non ESBL (n = 96) 58.3 48.9 23.9 8.3
ESBL (n = 31) 87.1 93.5 61.3 93.5
Klebsiella pneumoniae (n = 91) 48.3 74.7 45 68.1
   Non ESBL (33) 51.5 48.5 6.1 12.1
ESBL (58) 72.4 89.6 20.7 100
Proteus spp (n = 31) 58.4 - 0 16.3
   Non ESBL (29) 55.1 - 0 10.3
ESBL (2) 100.0 - 0 100.0
Other enterobacteria (n = 43) 72 44.2 21 34.8
   Non ESBL (n = 31) 61.3 38.7 12.9 9.6
ESBL (n = 12) 100.0 58.3 41.6 100.0
Pseudomonas spp (n = 46) 97.8 93.5 19.6 34.8
  1. SXT = Sulphamethaxazole/trimethoprim, TE = tetracycline, CIP = ciprofloxacin, and G = Gentamicin